Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus

Lisa A Tell, Karl V. Clemons, Yvonne Kline, Leslie Woods, Philip H Kass, Marife Martinez, David A. Stevens

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Aspergillus fumigatus causes disease in birds. Our objectives were to determine pharmacokinetic parameters and evaluate efficacy of voriconazole (VCZ) in a novel experimental quail model. After a single oral VCZ dose of 20 or 40 mg/kg, plasma concentrations peaked 2 h postdose (5.8 and 6.9 μg/ml) and remained above 0.5 μg/ml for 4 and 12 h postdose, respectively. For the efficacy study, ten-day-old Japanese quail (n 60) were infected intratracheally with A. fumigatus conidia. Daily oral VCZ at 20 or 40 mg/kg was initiated 24 h postinfection (PI); infected diluent-treated birds were given de-ionized water orally. Preassigned birds were euthanized on days 5 or 10 PI. VCZ at 40 mg/kg prolonged survival compared to 20 mg/kg or diluent-treatment (P < 0.05) and lungs from birds given VCZ at 40 mg/kg had fewer colony forming units (CFU) than diluent-treated (P =0.03). At day 10 PI, birds treated with VCZ at 20 mg/kg had significantly fewer fungi in the lungs as demonstrated by methenamine silver stain (P =0.017) or immunohistochemistry, as compared to diluent-treated (P =0.034). Histopathologically, VCZ-treated birds did not have necrotic lesions and showed a trend toward fewer with acute inflammatory changes. VCZ at 40 mg/kg was efficacious in quail with experimental pulmonary aspergillosis.

Original languageEnglish (US)
Pages (from-to)234-244
Number of pages11
JournalMedical Mycology
Volume48
Issue number2
DOIs
StatePublished - 2010

Fingerprint

Coturnix
Aspergillus fumigatus
birds
Birds
lungs
quails
mouth
Quail
bird diseases
aspergillosis
lesions (animal)
silver
Bird Diseases
pharmacokinetics
conidia
immunohistochemistry
Methenamine
Pulmonary Aspergillosis
Lung
Fungal Spores

Keywords

  • Antifungal
  • Aspergillosis
  • Avian
  • Fungal infection
  • Voriconazole

ASJC Scopus subject areas

  • veterinary(all)
  • Infectious Diseases

Cite this

Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus. / Tell, Lisa A; Clemons, Karl V.; Kline, Yvonne; Woods, Leslie; Kass, Philip H; Martinez, Marife; Stevens, David A.

In: Medical Mycology, Vol. 48, No. 2, 2010, p. 234-244.

Research output: Contribution to journalArticle

Tell, Lisa A ; Clemons, Karl V. ; Kline, Yvonne ; Woods, Leslie ; Kass, Philip H ; Martinez, Marife ; Stevens, David A. / Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus. In: Medical Mycology. 2010 ; Vol. 48, No. 2. pp. 234-244.
@article{2ee4791c902a4ddca68bbd20c96b81d9,
title = "Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus",
abstract = "Aspergillus fumigatus causes disease in birds. Our objectives were to determine pharmacokinetic parameters and evaluate efficacy of voriconazole (VCZ) in a novel experimental quail model. After a single oral VCZ dose of 20 or 40 mg/kg, plasma concentrations peaked 2 h postdose (5.8 and 6.9 μg/ml) and remained above 0.5 μg/ml for 4 and 12 h postdose, respectively. For the efficacy study, ten-day-old Japanese quail (n 60) were infected intratracheally with A. fumigatus conidia. Daily oral VCZ at 20 or 40 mg/kg was initiated 24 h postinfection (PI); infected diluent-treated birds were given de-ionized water orally. Preassigned birds were euthanized on days 5 or 10 PI. VCZ at 40 mg/kg prolonged survival compared to 20 mg/kg or diluent-treatment (P < 0.05) and lungs from birds given VCZ at 40 mg/kg had fewer colony forming units (CFU) than diluent-treated (P =0.03). At day 10 PI, birds treated with VCZ at 20 mg/kg had significantly fewer fungi in the lungs as demonstrated by methenamine silver stain (P =0.017) or immunohistochemistry, as compared to diluent-treated (P =0.034). Histopathologically, VCZ-treated birds did not have necrotic lesions and showed a trend toward fewer with acute inflammatory changes. VCZ at 40 mg/kg was efficacious in quail with experimental pulmonary aspergillosis.",
keywords = "Antifungal, Aspergillosis, Avian, Fungal infection, Voriconazole",
author = "Tell, {Lisa A} and Clemons, {Karl V.} and Yvonne Kline and Leslie Woods and Kass, {Philip H} and Marife Martinez and Stevens, {David A.}",
year = "2010",
doi = "10.3109/13693780903008821",
language = "English (US)",
volume = "48",
pages = "234--244",
journal = "Medical Mycology",
issn = "1369-3786",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Efficacy of voriconazole in Japanese quail (Coturnix japonica) experimentally infected with Aspergillus fumigatus

AU - Tell, Lisa A

AU - Clemons, Karl V.

AU - Kline, Yvonne

AU - Woods, Leslie

AU - Kass, Philip H

AU - Martinez, Marife

AU - Stevens, David A.

PY - 2010

Y1 - 2010

N2 - Aspergillus fumigatus causes disease in birds. Our objectives were to determine pharmacokinetic parameters and evaluate efficacy of voriconazole (VCZ) in a novel experimental quail model. After a single oral VCZ dose of 20 or 40 mg/kg, plasma concentrations peaked 2 h postdose (5.8 and 6.9 μg/ml) and remained above 0.5 μg/ml for 4 and 12 h postdose, respectively. For the efficacy study, ten-day-old Japanese quail (n 60) were infected intratracheally with A. fumigatus conidia. Daily oral VCZ at 20 or 40 mg/kg was initiated 24 h postinfection (PI); infected diluent-treated birds were given de-ionized water orally. Preassigned birds were euthanized on days 5 or 10 PI. VCZ at 40 mg/kg prolonged survival compared to 20 mg/kg or diluent-treatment (P < 0.05) and lungs from birds given VCZ at 40 mg/kg had fewer colony forming units (CFU) than diluent-treated (P =0.03). At day 10 PI, birds treated with VCZ at 20 mg/kg had significantly fewer fungi in the lungs as demonstrated by methenamine silver stain (P =0.017) or immunohistochemistry, as compared to diluent-treated (P =0.034). Histopathologically, VCZ-treated birds did not have necrotic lesions and showed a trend toward fewer with acute inflammatory changes. VCZ at 40 mg/kg was efficacious in quail with experimental pulmonary aspergillosis.

AB - Aspergillus fumigatus causes disease in birds. Our objectives were to determine pharmacokinetic parameters and evaluate efficacy of voriconazole (VCZ) in a novel experimental quail model. After a single oral VCZ dose of 20 or 40 mg/kg, plasma concentrations peaked 2 h postdose (5.8 and 6.9 μg/ml) and remained above 0.5 μg/ml for 4 and 12 h postdose, respectively. For the efficacy study, ten-day-old Japanese quail (n 60) were infected intratracheally with A. fumigatus conidia. Daily oral VCZ at 20 or 40 mg/kg was initiated 24 h postinfection (PI); infected diluent-treated birds were given de-ionized water orally. Preassigned birds were euthanized on days 5 or 10 PI. VCZ at 40 mg/kg prolonged survival compared to 20 mg/kg or diluent-treatment (P < 0.05) and lungs from birds given VCZ at 40 mg/kg had fewer colony forming units (CFU) than diluent-treated (P =0.03). At day 10 PI, birds treated with VCZ at 20 mg/kg had significantly fewer fungi in the lungs as demonstrated by methenamine silver stain (P =0.017) or immunohistochemistry, as compared to diluent-treated (P =0.034). Histopathologically, VCZ-treated birds did not have necrotic lesions and showed a trend toward fewer with acute inflammatory changes. VCZ at 40 mg/kg was efficacious in quail with experimental pulmonary aspergillosis.

KW - Antifungal

KW - Aspergillosis

KW - Avian

KW - Fungal infection

KW - Voriconazole

UR - http://www.scopus.com/inward/record.url?scp=76649134835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76649134835&partnerID=8YFLogxK

U2 - 10.3109/13693780903008821

DO - 10.3109/13693780903008821

M3 - Article

C2 - 19548171

AN - SCOPUS:76649134835

VL - 48

SP - 234

EP - 244

JO - Medical Mycology

JF - Medical Mycology

SN - 1369-3786

IS - 2

ER -